10.02.2010 - German drug company Boehringer Ingelheim is in talks to make Japanese subsidiary SSP wholly-owned in a deal worth more than $335 million, the Nikkei newspaper reported. Boehringer...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)